APRIL 23, 2015 — Two powerhouses of cancer support — the American Association for Cancer Research (AACR) and the Pancreatic Cancer Action Network (PanCAN)-- have jointly awarded Georgetown Lombardi Comprehensive Cancer Center and Thomas Jefferson University in Philadelphia $ 1 million over three years to determine whether
molecularly tailored treatment for pancreatic cancer improves survival compared with the current standard of care.